PGEN

Insider trade Sale by Shah Rutul R (Chief Operating Officer)

18h ago

Insider trade Sale by Lehr Donald P. (Chief Legal Officer)

18h ago

Insider trade Sale by Thomasian Harry Jr. (Chief Financial Officer)

18h ago

Insider trade Sale by Tennant Phil (Chief Commercial Officer)

18h ago

Insider trade Sale by Sabzevari Helen (President and CEO)

18h ago

News Precigen Soars: Biologics License Application Submission For PRGN-2012 Targets First FDA-Approved Recurrent Respiratory Papillomatosis Treatment

14d ago

News Precigen anticipates funding through cash flow breakeven by end of 2026 as PAPZIMEOS launch scales

19d ago

News Precigen GAAP EPS of -$0.02 beats by $0.02, revenue of $23.25M beats by $2.45M

19d ago

News Precigen expects Q1 revenue to exceed $18M as PAPZIMEOS launch accelerates with broad U.S. payer coverage

68d ago

SEC filing PGEN Reports $3.4M Q4 Revenue, FDA Approval of PAPZIMEOS, $100.4M Cash, J-Code Assigned

68d ago

News Patient Capital Bets Big on Precigen (PGEN) By Acquiring 10.2 Million Shares

153d ago

Scanner Unusual volume (z=7.8)

160d ago

Scanner Unusual volume (z=8.3)

161d ago

Scanner Unusual volume (z=8.3)

163d ago

Scanner Unusual volume (z=8.3)

164d ago

Scanner Unusual volume (z=3.8)

165d ago